FR 
EN Linearis ouvre un nouveau laboratoire afin d’offrir une plateforme analytique d’IA et de biomarqueurs pour l’innovation contre le cancer, le diabète, la résistance aux antimicrobiens et d’autres maladies métaboliques
Québec, Canada, November 28, 2023- Linearis Labs Inc (“Linearis”), an innovative company at the intersection of AI and biomarker analysis, announces today the inauguration of its new laboratory facilities at a site formerly occupied by Medicago Inc (“Medicago”). Following the announcement of the cessation of their operations after 26 years, Linearis acquired over 650 scientific…
Flexible protein database based on amino acid k-mers
Déraspe M, et al., Sci Rep.
Generative Flow Networks
Bengio et al.
On the robustness of generalization of drug-drug interaction models. BMC Bioinformatics
Kpanou R, et al., BMC Bioinformatics.
Machine learning analysis identifies genes differentiating triple negative breast cancers
Kothari C, et al., Sci Rep.
Metabolomics for investigating physiological and pathophysiological processes
Wishart DS., Physiol Rev.
Mass spectra alignment using virtual lock-masses
Brochu F, et al., Sci Rep.
Predicting Ion Mobility Collision Cross-Sections Using a Deep Neural Network: DeepCCS
Plante PL, et al., Anal Chem.
Interpretable genotype-to-phenotype classifiers with performance guarantees
Drouin A, et al., Sci Rep.